Children's Hospital is part of the UPMC family.
Our Sites
Be safe anytime, anywhere.
To find a pediatrician or pediatric specialist, please call 412-692-7337 or search our directory.
A resource for our network of referring physicians.
For more information about research, please call our main office at 412-692-6438.
Ranked #8 Nationally by U.S. News & World Report.
The purpose of this study is to determine whether patients who receive a hematopoietic stem cell transplant (HSCT) as part of therapy for a non-malignant disorder of the bone marrow can benefit from reduced-intensity conditioning (RIC) rather than the standard myeloablative conditioning. As part of standard preparation for conditions treated with HSCT, chemotherapy is provided in advance to reduce the chance that the patient’s body will reject the donor stem cells. While the highest tolerable chemotherapy is administered for malignant (cancer) cases, researchers believe that for non-malignant cases, RIC will reduce harmful side effects and lead to improved quality of life following treatment.
Subject to certain exclusion criteria, the study is accepting participants of both genders between the ages of 2 months and 55 years , who have a non-malignant disease that can be treated with a HSCT. Males: 2 months to 55 years old Females: 2 months to 55 years old
Prior to HSCT, participants will be placed into one of three study groups based on their conditions. Patients with or without immune deficiency and with a normal or near normal lymphocyte count will receive standard myeloablative conditioning. Patients with moderate lymphopenia or without lymphopenia but a recent history of CMV, adenovirus, RSV, or Parainfluenza 3 infections will received a half dose of the chemotherapy provided in the first group. The third group will be comprised of patients with severe lymphopenia and will be provided a test dose of the chemotherapy combination. Visits: Requires hospitalization for the transplant and chemotherapy that precedes transplant Duration: Patients will be followed at 3-month intervals in the first year, and thereafter annually.
Study Description from the National Institutes of Health
Paul Szabolcs, MD
For information about the study or enrollment, please contact: Shawna McIntyre, Clinical Research Supervisor 412-692-5552
*Original research initiated by investigators at UPMC Children’s Hospital of Pittsburgh.
Children's Hospital's main campus is located in the Lawrenceville neighborhood. Our main hospital address is:
UPMC Children’s Hospital of Pittsburgh One Children’s Hospital Way 4401 Penn Ave. Pittsburgh, PA 15224
In addition to the main hospital, Children's has many convenient locations in other neighborhoods throughout the greater Pittsburgh region.
With MyCHP, you can request appointments, review test results, and more.
For questions about a hospital bill call:
To pay your bill online, please visit UPMC's online bill payment system.
Interested in giving to Children's Hospital? Support the hospital by making a donation online, joining our Heroes in Healing monthly donor program, or visiting our site to learn about the other ways you can give back.